Connection

Mark Rubinstein to Antibodies, Bispecific

Back to Details
This is a "connection" page, showing publications Mark Rubinstein has written about Antibodies, Bispecific.
Mark Rubinstein
Connection Strength
0.807
Antibodies, Bispecific
  1. Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy. Cancer Discov. 2022 05 02; 12(5):1184-1186.
    View in: PubMed
    Score: 0.807
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.